Satellos Bioscience MSLE
NASDAQ MSLE
$6.75 -0.45 (-6.25%)
At close: Nov 11, 2026 · 4:00 PM EST

Satellos Bioscience (MSLE) Common Equity (2023 - 2026)

Updated

Satellos Bioscience (MSLE) reported Common Equity of $59.91 million for the quarter ended Jun 30, 2026, down 15.2% from the prior quarter.

Analysis

Satellos Bioscience (MSLE) Common Equity (2023 - 2026) Analysis & Trends

As of Dec 31, 2025, Satellos Bioscience posted Common Equity of $27.78 million, down 41.1% from the prior year.

  • By year, Common Equity came in at $47.16 million in the year ended Dec 31, 2024 (+53.3%) and $30.76 million in the year ended Dec 31, 2023.
  • Five-year quarterly Common Equity spans a low of $27.78 million in the quarter ended Dec 31, 2025 and a high of $70.66 million in the quarter ended Mar 31, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 40.27 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 81.53 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -4.58 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 44.95 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 51.81 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 14.35 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 13.04 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 89.30 Bn
10 Satellos Bioscience 109.60 Mn -98.54 Mn - 59.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 59.91 Mn
Mar 31, 2026 70.66 Mn
Dec 31, 2025 27.78 Mn
Dec 31, 2024 47.29 Mn
Dec 31, 2023 30.74 Mn
API Access

Satellos Bioscience Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=MSLE&period=max&api_key=YOUR_API_KEY